Risk factors for pneumonitis in solid tumors treated with anti-programmed death-1 therapy: A case-control study.

被引：1
|
作者：
Cui, Pengfei
Liu, Zhefeng
Wang, Guoqiang
Ma, Junxun
Qian, Yuanyu
Zhang, Fan
Han, Chun
Long, Yaping
Li, Ye
Zheng, Xuan
Sun, Danyang
Zhang, Jing
Cai, Shangli
Jiao, Shun Chang
Hu, Yi
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Med Oncol 1, Beijing, Peoples R China
[2] Gen Hosp PLA, Beijing, Peoples R China
[3] 3D Med Inc, Dept Med, Shanghai, Peoples R China
[4] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[5] Chinese Peoples Liberat Army Gen Hosp, Dept Oncol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15132
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Risk factors for pneumonitis in patients treated with anti-programmed death-1 therapy: A case-control study
    Cui, Pengfei
    Liu, Zhefeng
    Wang, Guoqiang
    Ma, Junxun
    Qian, Yuanyu
    Zhang, Fan
    Han, Chun
    Long, Yaping
    Li, Ye
    Zheng, Xuan
    Sun, Danyang
    Zhang, Jing
    Cai, Shangli
    Jiao, Shunchang
    Hu, Yi
    CANCER MEDICINE, 2018, 7 (08): : 4115 - 4120
  • [2] Risk factors for and characteristics of pneumonitis in patients treated with anti-programmed death-1 therapy.
    Hu, Yi
    Cui, Pengfei
    Zhang, Jing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [3] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Naidoo, Jarushka
    Wang, Xuan
    Woo, Kaitlin M.
    Iyriboz, Tunc
    Halpenny, Darragh
    Cunningham, Jane
    Chaft, Jamie E.
    Segal, Neil H.
    Callahan, Margaret K.
    Lesokhin, Alexander M.
    Rosenberg, Jonathan
    Voss, Martin H.
    Rudin, Charles M.
    Rizvi, Hira
    Hou, Xue
    Rodriguez, Katherine
    Albano, Melanie
    Gordon, Ruth-Ann
    Leduc, Charles
    Rekhtman, Natasha
    Harris, Bianca
    Menzies, Alexander M.
    Guminski, Alexander D.
    Carlino, Matteo S.
    Kong, Benjamin Y.
    Wolchok, Jedd D.
    Postow, Michael A.
    Long, Georgina V.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07) : 709 - +
  • [4] Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy (vol 35, pg 709, 2017)
    Naidoo
    Long, Georgina
    Hellmann, Matthew
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (22) : 2590 - 2590
  • [5] Pulmonary Infiltrates in Patients Treated with Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
    Okada, A.
    Ota, K.
    Horimoto, K.
    Ibaraki, T.
    Murakami, S.
    Takenaka, H.
    Choh, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1079 - S1080
  • [6] Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy
    Hamid, Omid
    Carvajal, Richard D.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (06) : 847 - 861
  • [7] Myocarditis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy.
    Wang, Hanping
    Guo, Xiaoxiao
    Tian, Ran
    Si, Xiaoyan
    Zhang, Xiaotong
    Wang, Jiangshan
    Zhao, Haitao
    Zhang, Li
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy
    Shah, Kaustav P.
    Song, Haocan
    Ye, Fei
    Moslehi, Javid J.
    Balko, Justin M.
    Salem, Joe-Elie
    Johnson, Douglas B.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (07) : 851 - 855
  • [9] Pneumonitis in combined Anti-programmed Death-1 Immunotherapy and Radiation Therapy for Renal Cell Carcinoma
    Yu, Nathan Y.
    Deftos, Michael
    Wang, Clifford C.
    CUREUS, 2018, 10 (12):
  • [10] Adrenal Insufficiency Related to Anti-Programmed Death-1 Therapy
    Ariyasu, Ryo
    Horiike, Atsushi
    Yoshizawa, Takahiro
    Dotsu, Yosuke
    Koyama, Junji
    Saiki, Masafumi
    Sonoda, Tomoaki
    Nishikawa, Shingo
    Kitazono, Satoru
    Yanagitani, Noriko
    Nishio, Makoto
    ANTICANCER RESEARCH, 2017, 37 (08) : 4229 - 4232
12345